Verified peer comparison
CVS vs LLY
CVS Health Corporation compared with Eli Lilly and Company. This page compares both source-verified company profiles and does not introduce an unverified price target.
CVS
CVS Health Corporation
$189.43
- Open
- --
- High
- --
- Low
- --
- Market Cap
- --
LLY
Eli Lilly and Company
$782.10
- Open
- --
- High
- --
- Low
- --
- Market Cap
- --
Company-specific comparison
Business exposure
CVS: Health Care Services
LLY: Pharmaceuticals
Upside lens
CVS: Pricing, benefit redesign and membership actions can improve alignment between premiums and medical costs. Insurance, PBM, pharmacy and care-delivery assets can coordinate access and lower total care costs. Retail and specialty pharmacy scale can support purchasing economics and recurring prescription relationships.
LLY: obesity drug adoption and pipeline expansion
Risk lens
CVS: Higher utilization or acuity can outpace pricing and pressure insurance margins. Rebate, transparency and pharmacy-reimbursement reforms could alter Caremark economics. Leverage and complexity across acquired care assets can limit capital flexibility and delay returns.
LLY: supply constraints and valuation expectations
Verified sources
CVS Health Reports First Quarter 2026 ResultsCVS Health Corporation · earningsVerified
CVS Health Corporation Investor RelationsCVS Health Corporation · companyVerified
Fetched: 7/12/2026, 12:00:00 AM UTC
Open original sourceCVS Health SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified
Lilly Reports First-Quarter 2026 Financial ResultsEli Lilly and Company · earningsVerified
Eli Lilly Investor RelationsEli Lilly and Company · companyVerified
Fetched: 7/11/2026, 12:00:00 AM UTC
Open original sourceForm 10-Q for the Quarter Ended March 31, 2026Eli Lilly and Company · filingVerified
LLY editorial research profileAlphaVue Research · editorialVerified
Fetched: 7/11/2026, 12:00:00 AM UTC